These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8417119)

  • 1. Effector functions of a mouse IgG that lacks the entire CH1 domain. C1q binding and complement fixation in the absence of antigen.
    Mizutani R; Igarashi T; Tanaka T; Shimada I; Arata Y
    J Immunol; 1993 Jan; 150(1):131-8. PubMed ID: 8417119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A matched set of rat/mouse chimeric antibodies. Identification and biological properties of rat H chain constant regions mu, gamma 1, gamma 2a, gamma 2b, gamma 2c, epsilon, and alpha.
    Brüggemann M; Teale C; Clark M; Bindon C; Waldmann H
    J Immunol; 1989 May; 142(9):3145-50. PubMed ID: 2496159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role for the third constant domain of the IgG H chain in activation of complement in the presence of C1 inhibitor.
    Okada M; Utsumi S
    J Immunol; 1989 Jan; 142(1):195-201. PubMed ID: 2491872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Domain-switched mouse IgM/IgG2b hybrids indicate individual roles for C mu 2, C mu 3, and C mu 4 domains in the regulation of the interaction of IgM with complement C1q.
    Chen FH; Arya SK; Rinfret A; Isenman DE; Shulman MJ; Painter RH
    J Immunol; 1997 Oct; 159(7):3354-63. PubMed ID: 9317134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Highly efficient neutralization of HIV with recombinant CD4-immunoglobulin molecules.
    Traunecker A; Schneider J; Kiefer H; Karjalainen K
    Nature; 1989 May; 339(6219):68-70. PubMed ID: 2541344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of altered CH2-associated carbohydrate structure on the functional properties and in vivo fate of chimeric mouse-human immunoglobulin G1.
    Wright A; Morrison SL
    J Exp Med; 1994 Sep; 180(3):1087-96. PubMed ID: 8064227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural difference in the complement activation site of human IgG1 and IgG3.
    Michaelsen TE; Sandlie I; Bratlie DB; Sandin RH; Ihle O
    Scand J Immunol; 2009 Dec; 70(6):553-64. PubMed ID: 19906198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chimeric mouse human IgG3 antibodies with an IgG4-like hinge region induce complement-mediated lysis more efficiently than IgG3 with normal hinge.
    Norderhaug L; Brekke OH; Bremnes B; Sandin R; Aase A; Michaelsen TE; Sandlie I
    Eur J Immunol; 1991 Oct; 21(10):2379-84. PubMed ID: 1915551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular structural studies of effector functions of a mouse immunoglobulin G that lacks the entire CH1 domain: small-angle X-ray scattering, nanosecond fluorescence depolarization and stable isotope-aided NMR analyses.
    Mizutani R; Matsunaga C; Kouyama T; Sato M; Katsube Y; Kato K; Shimada I; Arata Y
    Mol Immunol; 1993 Dec; 30(18):1665-9. PubMed ID: 8272079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C1q binding to chimeric monoclonal IgG3 antibodies consisting of mouse variable regions and human constant regions with shortened hinge containing 15 to 47 amino acids.
    Sandlie I; Aase A; Westby C; Michaelsen TE
    Eur J Immunol; 1989 Sep; 19(9):1599-603. PubMed ID: 2792180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of biological activity among nonfucosylated therapeutic IgG1 antibodies with three different N-linked Fc oligosaccharides: the high-mannose, hybrid, and complex types.
    Kanda Y; Yamada T; Mori K; Okazaki A; Inoue M; Kitajima-Miyama K; Kuni-Kamochi R; Nakano R; Yano K; Kakita S; Shitara K; Satoh M
    Glycobiology; 2007 Jan; 17(1):104-18. PubMed ID: 17012310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of H chain V region on complement activation by immobilized immune complexes.
    Horgan C; Brown K; Pincus SH
    J Immunol; 1992 Jul; 149(1):127-35. PubMed ID: 1607649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The structural requirements for complement activation by IgG: does it hinge on the hinge?
    Brekke OH; Michaelsen TE; Sandlie I
    Immunol Today; 1995 Feb; 16(2):85-90. PubMed ID: 7888072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human IgG1 Cgamma1 domain is crucial for the bioactivity of the engineered anti-CD20 antibodies.
    Geng S; Feng J; Li Y; Kang X; Sun Y; Gu X; Huang Y; Chang H; Shen BF
    Cell Mol Immunol; 2007 Apr; 4(2):121-5. PubMed ID: 17484806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of complement by an IgG molecule without a genetic hinge.
    Brekke OH; Michaelsen TE; Sandin R; Sandlie I
    Nature; 1993 Jun; 363(6430):628-30. PubMed ID: 8510754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-translational modifications of immunoglobulin G: a mouse IgG variant that lacks the entire CH1 domain.
    Masuda K; Yamaguchi Y; Kato K; Kim HH; Takahashi N; Shimada I; Arata Y
    Mol Immunol; 1999; 36(15-16):993-1003. PubMed ID: 10698303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mapping of amino acid residues in the C mu 3 domain of mouse IgM important in macromolecular assembly and complement-dependent cytolysis.
    Arya S; Chen F; Spycher S; Isenman DE; Shulman MJ; Painter RH
    J Immunol; 1994 Feb; 152(3):1206-12. PubMed ID: 8301125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C1q binding properties of monomer and polymer forms of mouse IgM mu-chain variants. Pro544Gly and Pro434Ala.
    Taylor B; Wright JF; Arya S; Isenman DE; Shulman MJ; Painter RH
    J Immunol; 1994 Dec; 153(11):5303-13. PubMed ID: 7963582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Existence of different but overlapping IgG- and IgM-binding sites on the globular domain of human C1q.
    Zlatarova AS; Rouseva M; Roumenina LT; Gadjeva M; Kolev M; Dobrev I; Olova N; Ghai R; Jensenius JC; Reid KB; Kishore U; Kojouharova MS
    Biochemistry; 2006 Aug; 45(33):9979-88. PubMed ID: 16906756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A mutant human IgG molecule with only one C1q binding site can activate complement and induce lysis of target cells.
    Michaelsen TE; Thommesen JE; Ihle O; Gregers TF; Sandin RH; Brekke OH; Sandlie I
    Eur J Immunol; 2006 Jan; 36(1):129-38. PubMed ID: 16323243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.